$295.00
+1.70 (+0.580%)
At Close: Jun 03, 2026
Upcoming Ex-Dividend Dates: September 21-October 4, 2021
09:30am, Sunday, 19'th Sep 2021
We provide a summary of upcoming ex-dividend dates in a quick reference table. The table includes relevant data and key statistics as well as the next payout and pay date.
Stryker's (SYK) Trauma & Extremities Arm Unveils New Product
09:55am, Friday, 17'th Sep 2021
The newly launched Citrelock Tendon Fixation Device System expands Stryker's (SYK) Foot & Ankle offerings.
Stryker Corp: A Health Care Company You Shouldn't Ignore
11:53am, Tuesday, 14'th Sep 2021
Medical device companies are gradually seeing a rebound in their business as fewer elective medical visits, procedures and surgeries are being delayed due to Covid-19.
Final Trades: Stryker, Editas Medicine, Oracle & more
02:17pm, Monday, 13'th Sep 2021
The "Halftime Report" traders give their top picks to watch for the second half.
Stryker (SYK) Hits New 52-Week High: What's Driving It?
12:39pm, Thursday, 09'th Sep 2021
Investors are optimistic about Stryker's (SYK) strength in robotics and its diversified product portfolio.
Stryker Acquires Provider Of Blood Loss Monitoring Platform
06:49am, Wednesday, 08'th Sep 2021
Stryker Corporation (NYSE: SYK) has acquired Gauss Surgical for an undisclosed consideration. Gauss Surgical is a medical device company that has developed Triton, an artificial intelligence-enabl
Here's Why You Should Retain Stryker (SYK) Stock Right Now
11:24am, Thursday, 02'nd Sep 2021
Stryker (SYK) continues to benefit from strength in the robotic-arm assisted surgery platform, Mako, and broad product portfolio. However, pricing pressure raises a concern.
Stuart F. Simpson is THINK Surgical's New President and Chief Executive Officer
08:15pm, Wednesday, 01'st Sep 2021
FREMONT, Calif., Sept. 1, 2021 /PRNewswire/ -- THINK Surgical, Inc., an innovator in the field of orthopedic surgical robots, today announced the appointment of Stuart F.
Stryker to participate in Morgan Stanley's 19th Annual Global Healthcare Conference
08:30am, Monday, 30'th Aug 2021
Kalamazoo, Michigan, Aug. 30, 2021 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) will participate in Morgan Stanley's 19th Annual Global Healthcare Conference on Monday, September 13, 2021.
This Revolutionary Medical Device Company Goes to 11
06:12am, Friday, 13'th Aug 2021
To stand tall against a competitive market, NuVasive depends on a strong spinal platform.
The Highest Quality Dividend Growth Stocks
02:01pm, Tuesday, 03'rd Aug 2021
This article updates one published by David Van Knapp in June 2020.
Why Stryker (SYK) is a Top Growth Stock for the Long-Term
02:28pm, Thursday, 29'th Jul 2021
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Stryker Corporation's (SYK) CEO Kevin Lobo on Q2 2021 Results - Earnings Call Transcript
09:08pm, Tuesday, 27'th Jul 2021
Stryker Corporation's (SYK) CEO Kevin Lobo on Q2 2021 Results - Earnings Call Transcript
Stryker (SYK) Q2 Earnings and Revenues Beat Estimates
07:09pm, Tuesday, 27'th Jul 2021
Stryker (SYK) delivered earnings and revenue surprises of 6.13% and 4.08%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?
FDA OK's Stryker's Implantable, Biodegradable Balloon Spacer For Shoulder Injury
02:21pm, Tuesday, 13'th Jul 2021
More than a decade after receiving European CE mark approval, an implantable balloon spacer, InSpace, recently acquired by Stryker Corp (NYSE:SYK), will make its U.S. debut after FDA approval. The
Sign In
Buy SYK